Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization

Bernd Dielacher's Biography



Bernd Dielacher, Business Development Manager, EV Group (EVG)

Dr. Bernd Dielacher is business development manager at EV Group, where he is focused on nanoimprint and bonding solutions for the bio- and medical technology market.

Bernd holds a master’s degree in Microelectronics from Vienna University of Technology and received a PhD in Biomedical Engineering from ETH Zurich, where he explored metal nanostructures for electrical and plasmonic sensing in biomedical applications.

Bernd Dielacher Image

Industrial Implementation of Imprint and Bonding Technology for Lab-on-a-Chip Devices

Tuesday, 3 October 2017 at 16:45

Add to Calendar ▼2017-10-03 16:45:002017-10-03 17:45:00Europe/LondonIndustrial Implementation of Imprint and Bonding Technology for Lab-on-a-Chip DevicesSELECTBIOenquiries@selectbiosciences.com

To successfully commercialize modern chip-based biotechnology devices in a fast growing market with stringent requirements and high regulatory hurdles, precise and cost-effective micro- and nano-structuring technologies are essential. Nanoimprint lithography (NIL), such as hot embossing and UV-NIL, has evolved from a niche technology to a powerful high-volume manufacturing method that is able to serve today’s needs and overcome the challenges of increasing complexity of microfluidic and lab-on-a-chip devices. This presentation will discuss NIL as a cost-effective large-area industrial structuring technology for lab-on-a-chip devices as well as corresponding bonding processes for device sealing.


Add to Calendar ▼2017-10-02 00:00:002017-10-04 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics: Companies, Technologies and CommercializationSELECTBIOenquiries@selectbiosciences.com